Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
BB Biotech AG reported a 6.20% stake in Agios Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
BB Biotech AG reported a 6.20% stake in Agios Pharmaceuticals, Inc., 3,515,150 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 3,515,150
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BB Biotech AG | 6.20% | 3,515,150 |
| Biotech Target N.V. | 6.20% | 3,515,150 |
Source
Related
- Agios Pharmaceuticals, Inc.
- BB Biotech AG
- Agios Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BB Biotech AG · Jun 13, 2025
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026